STUART ARNOLD FINE
Medical Practice in Northbrook, IL
License number
Pennsylvania MD060231L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Northbrook, IL 60062
Pennsylvania
Pennsylvania
Personal information
See more information about STUART ARNOLD FINE at radaris.comName
Address
Phone
747 N Wabash Ave APT 1203, Chicago, IL 60611
618 Cedar Hill Rd, Ambler, PA 19002
2230 White Oak Dr, Northbrook, IL 60062
531 Parkside Dr, Palatine, IL 60067
55 E Erie St #3305, Chicago, IL 60611
Professional information
See more information about STUART ARNOLD FINE at trustoria.com
Combinations Of Vanadium With Antidiabetics For Glucose Metabolism Disorders
Combinations Of Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2007020, Sep 6, 2007
Filed:
Jan 24, 2007
Appl. No.:
11/657401
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
Assignee:
Akesis Pharmaceuticals - La Jolla CA
International Classification:
A61K 33/24
US Classification:
424646000, 424655000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2005023, Oct 20, 2005
Filed:
Mar 23, 2005
Appl. No.:
11/088272
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
International Classification:
A61K038/28, A61K031/555, A61K031/426, A61K031/175, A61K031/155
US Classification:
514003000, 514184000, 514369000, 514592000, 514635000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium With Antidiabetics For Glucose Metabolism Disorders
Combinations Of Chromium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2007019, Aug 23, 2007
Filed:
Jan 22, 2007
Appl. No.:
11/656351
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
Assignee:
Akesis Pharmaceuticals - La Jolla CA
International Classification:
A61K 38/28, A61K 31/555, A61K 31/155, A61K 31/4439, A61K 31/426, A61K 31/192
US Classification:
514003000, 514184000, 514342000, 514369000, 514025000, 514594000, 514635000, 514569000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium Or Vanadium With Antidiabetics
Combinations Of Chromium Or Vanadium With Antidiabetics
US Patent:
2005023, Oct 20, 2005
Filed:
Mar 23, 2005
Appl. No.:
11/088273
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
International Classification:
A61K038/28, A61K031/555, A61K031/426, A61K031/175, A61K031/155
US Classification:
514003000, 514184000, 514369000, 514592000, 514635000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Vanadium With Antidiabetics For Glucose Metabolism Disorders
Combinations Of Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2007019, Aug 23, 2007
Filed:
Jan 5, 2007
Appl. No.:
11/650343
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
Assignee:
Akesis Pharmaceuticals - La Jolla CA
International Classification:
A61K 38/28, A61K 31/7034, A61K 31/555, A61K 31/155, A61K 31/4439, A61K 31/426, A61K 31/17, A61K 31/19
US Classification:
424646000, 514594000, 514003000, 514342000, 514369000, 514635000, 514569000, 514184000, 514025000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2005028, Dec 22, 2005
Filed:
May 31, 2005
Appl. No.:
11/141265
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
International Classification:
A61K031/555, A61K031/175, A61K031/155, A61K031/426
US Classification:
514184000, 514592000, 514635000, 514369000, 514003000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Dietary Supplement And Method Of Treatment For Diabetic Control
Dietary Supplement And Method Of Treatment For Diabetic Control
US Patent:
5962030, Oct 5, 1999
Filed:
Nov 5, 1997
Appl. No.:
8/964814
Inventors:
Stuart A. Fine - Northbrook IL
Assignee:
Akesis Pharmaceuticals, Inc. - La Jolla CA
International Classification:
A61K 3326, A61K 3324, A61K 3314, A61K 3306, A61K 3160
US Classification:
424646
Abstract:
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2007016, Jul 12, 2007
Filed:
Nov 22, 2006
Appl. No.:
11/603931
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
Assignee:
Akesis Pharmaceuticals - La Jolla CA
International Classification:
A61K 38/28, A61K 31/555, A61K 31/426, A61K 31/192, A61K 31/155, A61K 31/17
US Classification:
514003000, 514184000, 514594000, 514635000, 514369000, 514568000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2006000, Jan 5, 2006
Filed:
Jun 1, 2005
Appl. No.:
11/142807
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
International Classification:
A61K 31/555, A61K 31/4439, A61K 31/426, A61K 31/175, A61K 31/155
US Classification:
514184000, 514369000, 514340000, 514592000, 514635000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Dietary Supplement And Method Of Treatment For Diabetic Control
Dietary Supplement And Method Of Treatment For Diabetic Control
US Patent:
6203819, Mar 20, 2001
Filed:
Mar 19, 1999
Appl. No.:
9/272819
Inventors:
Stuart A. Fine - Northbrook IL
Assignee:
Akesis Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 3326, A61K 3324, A61K 3314, A61K 3160, A61K 31355
US Classification:
424646
Abstract:
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.